Navigation Links
EnVivo Pharmaceuticals Research Shows EVP-6124 Acts as Acetylcholine Co-Agonist
Date:11/5/2010

memory function in these animals.

"Low doses of EVP-6124 could enhance current cholinergic treatments and when combined with available agents could provide a pro-cognitive effect for as long as acetylcholine is present in the brain," said Dr. Jeff Cummings, director of the Cleveland Clinic Lou Ruvo Center for Brain Health (Las Vegas, Nevada and Cleveland, Ohio).  "EnVivo's experimental results suggest that pro-cognitive drugs could be taken in earlier stages of Alzheimer's disease and that EVP-6124 could continue to boost the pro-cognitive effect of cholinesterase inhibitors throughout the disease course.  The effectiveness of reduced doses of cholinesterase inhibitors when given with EVP-6124 in experimental models suggests that EVP-6124 might allow use of lower doses with fewer side effects in humans."

The results of EnVivo's ongoing Phase IIb trial, expected in the second half of 2011, will hopefully further corroborate EnVivo's most recent findings.

About EnVivo Pharmaceuticals

EnVivo Pharmaceuticals, located in Watertown, Mass., is a biopharmaceutical company dedicated to discovering and developing small molecule therapeutics for disorders of the central nervous system, with a current focus on Alzheimer's disease, cognitive disorders and schizophrenia.  The company's lead product is an alpha-7 nicotinic acetylcholine receptor agonist and is currently in Phase IIb clinical trials for cognition disorders in Alzheimer's disease and schizophrenia.  The company's other programs include an epigenetics program based on Histone Deacetylase inhibition (HDACi) with EVP-0334 as the lead molecule which is in preparation for Phase II studies, and several preclinical programs such as a Gamma Secretase Modulator (for Alzheimer's disease) and a PDE10 inhibitor program (for schizophrenia), expected to enter the clinic in 2011.  For more information about'/>"/>

SOURCE EnVivo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EnVivo Pharmaceuticals Announces Significant Results from GSM Transgenic Mouse Model for Alzheimers Disease
2. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
3. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
4. Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
5. Neuraltus Pharmaceuticals Awarded $733,437 Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP)
6. Inspiration Biopharmaceuticals Awarded Two Grants Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP)
7. Savient Pharmaceuticals Announces Expected Availability of KRYSTEXXA™ for Prescription and Reports Third Quarter 2010 Financial Results
8. Penwest Pharmaceuticals Shareholders Approve Merger With Subsidiary of Endo Pharmaceuticals
9. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
10. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results
11. Onyx Pharmaceuticals to Present at the Credit Suisse 2010 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , February 27, 2015 ... sein bahnbrechendes Überwachungssystem für kongestive Herzinsuffizienz (CHF) ... -     ... die ein neuartiges Herzüberwachungssystem für Patienten mit ... bekannt, dass sie ein Finanzierungsvorhaben über 5 ...
(Date:2/26/2015)...  Finesse expands office in Leicester, United ... expansion of its operations in Leicester ... access for customers is expected shortly afterward. ... to the current office, the new premises will double ... allow Finesse to bring on more service personnel. The ...
(Date:2/26/2015)... , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... quarter and full year 2014 financial results after the market ... with the release, the Company will host a conference call ... on Thursday, March 5, 2015 to discuss ... Interested parties may access the live conference call via ...
Breaking Medicine Technology:Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2New Finesse Office in United Kingdom 2IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2
(Date:2/28/2015)... 2015 Memphis, TN: MedixSafe has retracted ... a new security reader named Guardian 2. The ... a new biometric scanner that significantly increases the ... the new biometric scanner provides fast and easy ... MedixSafe narcotics lockers with Vanguard technology ...
(Date:2/28/2015)... My Shiney Hiney® LLC., the renowned brand ... Las Vegas, Nevada for the annual ASD Market Week tradeshow. ... leading consumer-goods tradeshows and My Shiney Hiney will be one ... Shiney Hiney can be found at booth number C1663. , ... at-home personal hygiene brush and cleansing system exclusively created to ...
(Date:2/27/2015)... Sacramento, Calif. (PRWEB) February 27, 2015 ... of liver-disease death, between four and 12 years earlier ... study from UC Davis Health System. , While previous ... ALD than other populations, the new study -- published ... -- is believed to be the first to pinpoint ...
(Date:2/27/2015)... Santa Clara, CA (PRWEB) February 27, 2015 ... Integrated Passive Devices (IPD), has introduced miniature, wire bondable, ... Brightness and Power LED markets. The ESD88NP ... high transient currents away from sensitive LED and IC ... compared to Multilayer Varistors (MLV). All devices meet ...
(Date:2/27/2015)... Beverly Hills, CA (PRWEB) February 27, 2015 ... was in the air for those suffering from Sjögren’s ... had been discovered by researchers at the University of ... the next phase of research was to develop a ... to precisely detect the presence of new autoantibodies. Researchers ...
Breaking Medicine News(10 mins):Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2
... , THURSDAY, May 5 (HealthDay News) -- People with allergies ... is flooded, experts advise. Failure to remove contaminated materials ... been flooded can lead to long-term health risks, according to ... example, standing water and wet materials quickly lead to the ...
... just as effective as longer ones,- and a great ... cause pneumonia in children on temporary breathing devices, according ... May 3 in Clinical Infectious Diseases . ... antibiotics for respiratory infections while on a ventilator, longer ...
... Reston, Va. (May 5, 2011) Two articles in ... Medicine make a case for maintaining current U.S. ... patients who undergo radioactive iodine treatments for thyroid cancer, ... for patients receiving radioactive iodine after total or near-total ...
... The makers of cold and fever medications that contain the ... versions of the products to avoid confusion that might lead ... production ends, later this year, the companies will sell just ... Companies such as Johnson & Johnson currently sell infant versions ...
... This release is available in German . ... severe symptoms, which include shortness of breath, exhaustion and a ... in women, often claims the patient,s life within a few ... can slow down the progression of the disease and improve ...
... Tests of a new antibody-based "biosensor" developed by researchers at ... detect marine pollutants like oil much faster and more cheaply ... to be used from a boat. Testing of the ... drain into lower Chesapeake Bay, shows that the instrument can ...
Cached Medicine News:Health News:Short antibiotic courses safer for breathing-tube infections in children 2Health News:The case for maintaining current regulations on I-131 therapy 2Health News:Drugmakers to End Infant Formulas of Products With Acetaminophen 2Health News:Drugmakers to End Infant Formulas of Products With Acetaminophen 3Health News:When the lungs come under pressure 2Health News:When the lungs come under pressure 3Health News:Tests show new biosensor can guide environmental clean-ups 2Health News:Tests show new biosensor can guide environmental clean-ups 3Health News:Tests show new biosensor can guide environmental clean-ups 4
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
...
...
...
Medicine Products: